Chief, Vaccine Research at Harvard Medical School
First, there are major scientific and technical challenges in the development of an HIV vaccine. Many of them are being overcome. Others we are working on.
A second challenge is the bigger picture of how HIV vaccines will be implemented and how they will interact with other prevention modalities. HIV vaccines don't exist in a silo, but rather as a critical part of a more complex HIV prevention field.